secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001689548-22-000099
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis CMO Bernard Ravina to step down, become part-time strategic advisor
--------------------------------------------------------------------------

- Bernard Ravina, Chief Medical Officer, transitions to part-time strategic advisor effective Aug 1, 2022.
- Cash payment of $373,688 paid over consulting period ending May 1, 2023.
- Outstanding equity awards will continue to vest during consulting period subject to service.
- Health benefits continuation provided during consulting period; payment subject to signing release.
- Ravina resigns from all officer and director positions with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000168954822000099/0001689548-22-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000168954822000099/prax-20220721.htm
  HTML page:      https://secwatch.observer/filing/0001689548-22-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer